Skip to content

Evaluation the effect of ointment of pistacia Atlantica oil on primery knee osteoarthritis

Evaluation the effect of ointment of pistacia Atlantica oil on primery knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210513051279N1
Enrollment
92
Registered
2021-06-27
Start date
2021-07-22
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoarthritis of the knee. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: To prepare the medicine, pistacia Atlantica oil, which is traditionally oiled, is standardized and applied as ointment and packaged after standardization and qualit

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: age between 50 to 80 years osteoarthritis grade 1 to 3 according to Kellgren-Lawrence Classification of Osteoarthritis in X Ray severity of pain 3 to 8 in VAS scale

Exclusion criteria

Exclusion criteria: Attend another clinical study in the last 6 months Cognitive or mental disorder Taking oral and injectable corticosteroids in the last two months People who have a history of allergies to herbal medicines Patients with acute arthritis, osteoarthritis secondary to rheumatic diseases such as RA and gout, infectious arthritis, metabolic arthritis, traumatic arthritis, uncontrolled diabetes, known case of heart, liver, cancer Skin disease at the joint site Joint replacement through surgery Fiber myalgia, radiculopathy and neuropathy Patients taking glucosamine, chondroitin sulfate and muscle relaxants at the same time

Design outcomes

Primary

MeasureTime frame
Joint pain score in VAS questionnaire. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: VAS questionnaire score.;Joint pain score in KOOS questionnaire. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: KOOS questionnaire score.

Secondary

MeasureTime frame
Joint symptoms score in the KOOS questionnaire. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: Score in the KOOS questionnaire.;Activity of daily live score in the KOOS questionnaire. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: Score in the KOOS questionnaire.;Sport. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: Score in the KOOS questionnaire.;Quality of life. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of treatment and 4 weeks after the end of treatment. Method of measurement: Score in the KOOS questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Azizi

Babol University of Medical Sciences

F.azizi@mubabol.ac.ir+98 11 3219 4730

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026